Arena Pharma Stock
StockStockPrice
Frequently asked questions
What is Arena Pharma's market capitalization?
What is the Earnings Per Share (EPS) for Arena Pharma?
What are the analyst ratings and target price for Arena Pharma's stock?
What is Arena Pharma's revenue over the trailing twelve months?
What is the EBITDA for Arena Pharma?
What is the free cash flow of Arena Pharma?
What is the 5-year beta of Arena Pharma's stock?
How many employees does Arena Pharma have, and what sector and industry does it belong to?
What is the free float of Arena Pharma's shares?
Financials
Market Cap
$6.17B5Y beta
0.53EPS (TTM)
-$10.13Free Float
61.03MRevenue (TTM)
$54.00KEBITDA (TTM)
-$541.79MFree Cashflow (TTM)
-$523.00MAnalyst Ratings
The price target is $97.86 and the stock is covered by 8 analysts.
Buy
2
Hold
6
Sell
0
Information
Arena Pharmaceuticals Inc is a United States-based clinical stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of several immuno-inflammatory diseases. It delivers transformational medicines with optimized pharmacology and pharmacokinetics to patients globally. The Company's clinical programs include Etrasimod, which is an oral, selective sphingosine 1-phosphate (S1P), receptor modulator, designed to provide systemic and local cell modulation by targeting S1P receptor subtypes one, four and five.
448
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker